範科工業 GENC 深 滬
等待開盤 09-26 09:30:00 美东时间
14.45
-0.370
-2.50%
華盛通- 最 高14.89
- 今 開14.51
- 成交量 1.47万股
- 最 低 14.39
- 昨 收 14.82
- 總市值 2.12亿
- 52周最高 22.815
- 市盈率 靜 14.55
- 換手率 0.10%
- 52周最低 10.80
- 委 比 47.37%
- 總股本 1465.77万
- 歷史最高 24.88
- 量 比 0.36
- 振 幅 3.37%
- 歷史最低 4.4067
- 每 手 1
- 風險率 2.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Genco Shipping & Trading Announces Appointment of John C. Wobensmith as Chairman and Kathleen C. Haines as Lead Independent Director
Genco Shipping & Trading Limited announced that James G. Dolphin has retired from the Board after 11 years, with no disagreement on the company's strategy or operations. John C. Wobensmith has been appointed as Chairman, and Kathleen C. Haines as Lead Independent Director to strengthen governance. Dolphin expressed confidence in the company's future, highlighting its strong balance sheet and ability to deliver shareholder returns. Wobensmith emph...
08-28 20:15
Genco Shipping & Trading Limited to Participate in the Jefferies Industrials Conference
Genco Shipping & Trading Limited, the largest U.S.-based drybulk shipowner, announced that its CEO John C. Wobensmith, CFO Peter Allen, and Vice President Michael Orr will present at the Jefferies Industrials Conference on September 3, 2025. The presentation will be webcast via Genco’s Investor Relations website, and the company will also participate in investor meetings. Genco specializes in global transportation of commodities like iron ore, gr...
08-25 20:15
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
Generation Bio announced new data demonstrating their cell-targeted lipid nanoparticle (ctLNP) system successfully delivered siRNA to T cells in non-human primates, a first in the field. The system showed potent and selective knockdown of beta-2 microglobulin, LAT1, and VAV1, potentially addressing T cell-driven autoimmune diseases. The company reported a cash balance of $141.4 million as of June 30, 2025, and is evaluating strategic alternatives...
08-12 20:05
Bicycle Therapeutics Advances Pipeline Amid Strategic Realignment
Gencor Industries, Inc. ( ($GENC) ) has released its Q3 earnings. Here is a bre...
08-09 12:16
Gencor Industries Q3 EPS $0.26 Up From $0.17 YoY, Sales $26.986M Up From $25.551M YoY
Gencor Industries (NASDAQ:GENC) reported quarterly earnings of $0.26 per share. This is a 52.94 percent increase over earnings of $0.17 per share from the same period last year. The company reported $26.986 million in
08-08 19:21
Gencor Regains NYSE Compliance After Filing Delay
An announcement from Gencor ( ($GENC) ) is now available. Gencor Industries, In...
07-28 22:48
Gencor Industries shares are trading higher after the company reported a year-over-year increase in Q1 sales results.
Gencor Industries shares are trading higher after the company reported a year-o...
07-25 22:50
Gencor Industries Q2 EPS $0.42, Same YoY, Sales $38.204M Down From $40.676M YoY
Gencor Industries (NASDAQ:GENC) reported quarterly earnings of $0.42 per share. This is unchanged from the same period last year. The company reported $38.204 million in sales this quarter. This is a 6.08 percent
07-25 19:12
Gencor Releases First Quarter Fiscal 2025 Results
Gencor Industries reported a 20.7% increase in net revenue for Q4 2024 to $31.4 million, with higher contract equipment sales offsetting lower parts sales. Gross profit margin slightly declined to 27.6% due to parts sales' reduced contribution. Operating expenses decreased, leading to an 18.4% rise in operating income to $4.6 million. However, net income fell 12.0% to $3.8 million due to lower other income, primarily from marketable securities lo...
07-25 11:02
Gencor Adjusts Shareholder Proposal Deadline for Meeting
An announcement from Gencor ( ($GENC) ) is now available. Gencor Industries, In...
07-19 03:17
